Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 6/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.64 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | CACNA1C | Q13936 | 3/20 | 0.64 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.64 |
| ▸ | SCN1A | P35498 | 3/20 | 0.64 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.64 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.64 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.64 |
| ▸ | THPO | P40225 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10932847 | 0.90 | CACNA1C (0.58) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL7158381 | 0.90 | ADORA3 (0.80) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL6727785 | 0.85 | CACNA1D (0.72) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL7434487 | 0.85 | CYP1A2 (0.57) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL7425673 | 0.84 | ADORA3 (0.68) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL7264493 | 0.84 | ADORA3 (0.85) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL10858643 | 0.84 | CYP1A2 (0.59) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL10909420 | 0.84 | ADORA3 (0.77) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL7438852 | 0.83 | CYP1A2 (0.55) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 | |
| SCHEMBL7434261 | 0.83 | CYP2C9 (0.55) | CYP1A2HIF1ACYP2C9ADORA3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020119989-A1 | Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction | ANIONA APS (DK) | 2002-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119989-A1 | Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction | KCNN2, KCNN1, KCNJ2 | CYP1A2 3170/4885HIF1A 2396/4885CYP2C9 4565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.